Medical Equipment

The Increasing Prevalence Of Colorectal Cancer Is Driving The Polyp Biopsy Market Through Early Detection Needs Is Supporting Expansion In The Polyp Biopsy Market

April 15, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Polyp Biopsy Market Projected To Reach By 2030?

The polyp biopsy market has experienced robust expansion recently. This market is projected to expand from $1.39 billion in 2025 to $1.5 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 8.5%. Historically, this expansion has been driven by factors such as an increasing incidence of gastrointestinal and cervical cancers, advancements in endoscopic technologies, the proliferation of screening initiatives, greater understanding of the advantages of early diagnosis, and the establishment of more specialty clinics.

The polyp biopsy market is anticipated to experience substantial expansion over the coming years. By 2030, its value is projected to reach $2.06 billion, demonstrating a compound annual growth rate (CAGR) of 8.2%. This increase during the forecast period is primarily fueled by factors such as AI-assisted biopsy procedures, the adoption of minimally invasive techniques, the broader implementation in hospitals and diagnostic laboratories, integration with imaging and cloud platforms, and the creation of innovative biopsy tools. Key developments expected during this period involve colonoscopy biopsy, colposcopy-directed biopsy, esophagogastroduodenoscopy biopsy, laryngoscopy biopsy, and endoscopic mucosal resection (emr).

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/polyp-biopsy-global-market-report

What Key Factors Are Affecting The Polyp Biopsy Market Demand?

The rising incidence of colorectal cancer is anticipated to fuel the expansion of the polyp biopsy market in the future. Colorectal cancer, a malignant condition, develops in the colon or rectum due to the abnormal, unregulated proliferation of epithelial cells within the large intestine, and is known for its ability to invade adjacent tissues and spread to other organs. This escalating prevalence of colorectal cancer largely stems from prevalent dietary habits rich in processed items and deficient in fiber, factors that foster persistent inflammation, disrupt gut flora, and encourage the formation of precancerous growths that may eventually become malignant. Polyp biopsy serves to lessen the effect of the increasing colorectal cancer prevalence by facilitating the early identification and microscopic assessment of questionable lesions, thus aiding in prompt treatment and hindering the disease’s advancement. For example, the American Cancer Society (ACS), a US-based non-profit organization, forecasts that in 2025, approximately 107,320 new colon cancer cases and 46,950 rectal cancer cases are anticipated to be diagnosed in the United States, with around 52,900 deaths projected from these specific cancers. Consequently, the rising prevalence of colorectal cancer is propelling the growth of the polyp biopsy market.

Which Segment Classifications Are Used In The Polyp Biopsy Market Segment Analysis?

The polyp biopsy market covered in this report is segmented –

1) By Type: Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy

2) By Technique: Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), Conventional Biopsy

3) By Application: Colorectal Cancer, Gastrointestinal Disorders, Other Applications

4) By End-User: Hospitals, Specialty Clinics

Subsegments:

1) By Colonoscopy: Diagnostic Colonoscopy, Therapeutic Colonoscopy

2) By Colposcopy-Directed Biopsy: Cervical Biopsy, Vaginal Biopsy, Vulvar Biopsy

3) By Esophagogastroduodenoscopy: Diagnostic Esophagogastroduodenoscopy, Therapeutic Esophagogastroduodenoscopy

What Trends Are Influencing Changes In The Polyp Biopsy Market?

Leading companies within the polyp biopsy market are prioritizing the development of cutting-edge innovations, such as AI-assisted detection systems, with the goal of improving the identification of colorectal polyps and facilitating the prompt discovery of potential cancerous lesions. An AI-assisted detection system is a technology designed to analyze medical imaging instantaneously, pinpointing possible abnormalities and issuing visual notifications to clinicians, thereby supporting clinical decision-making without necessitating therapeutic interventions. For instance, in September 2024, Odin Medical Ltd., a US-based medical technology company affiliated with Olympus Corporation, introduced CADDIE, a cloud-based AI endoscopic system. The CADDIE device utilizes cloud-based artificial intelligence to analyze colonoscopy video in real time and highlight regions where colorectal polyps are suspected, empowering endoscopists to make well-informed choices during procedures. Clinical trials have shown that the system enhances the adenoma detection rate without prolonging procedural time or increasing associated risks, thereby highlighting its capacity to advance early detection and patient care.

Which Firms Are Contributing To The Polyp Biopsy Market Ecosystem?

Major companies operating in the polyp biopsy market are Johnson & Johnson (Ethicon), Medtronic plc, Medline Industries LP, FUJIFILM Holdings Corporation, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., CooperSurgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., Innovia Medical

Get The Full Polyp Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/polyp-biopsy-global-market-report

Where Is The Polyp Biopsy Market Primarily Concentrated By Region?

North America was the largest region in the polyp biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polyp biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Polyp Biopsy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/polyp-biopsy-global-market-report

Browse Through More Reports Similar to the Global Polyp Biopsy Market 2026, By The Business Research Company

Kidney Biopsy Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Liquid Biopsy For Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795